CapsoVision (CV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on CapsoVision (CV) is Neutral.

The composite score behind that read is -0.10, weighing +0.14 of bullish evidence against -0.24 bearish.

CapsoVision last closed at $6.58, +6.65% on the session.

Against the IVW growth benchmark the position is +5.73% over the forecast window.

The read is built from 11 underlying insights — 4 bullish and 7 bearish.

Agreement across those insights is 64%.

16 graded predictions for CV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks CapsoVision in the 6th percentile on return on equity, where 100 is best.

CapsoVision is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $328.22M.

StockMap tracks CapsoVision as the 82nd largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite CapsoVision ranks 35th of 133 in the group, against a group median of -0.21.